View
1
Download
0
Category
Preview:
Citation preview
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 1 / 28
Slide 2 / 28
Page 1
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 3 / 28
Slide 4 / 28
Page 2
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 5 / 28
Slide 6 / 28
Page 3
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 7 / 28
Slide 8 / 28
Page 4
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 9 / 28
Slide 10 / 28
Page 5
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 11 / 28
Slide 12 / 28
Page 6
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 13 / 28
Slide 14 / 28
Page 7
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 15 / 28
Slide 16 / 28
Page 8
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 17 / 28
Slide 18 / 28
Page 9
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 19 / 28
Slide 20 / 28
Page 10
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 21 / 28
Slide 22 / 28
Page 11
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 23 / 28
Slide 24 / 28
Page 12
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 25 / 28
Slide 26 / 28
Page 13
undefined
S6-04 PATIENT-REPORTED OUTCOME (PRO) RESULTS, NRG ONCOLOGY/NSABP B-35: A CLINICAL TRIAL OF ANASTROZOLE (A) VS TAMOXIFEN (TAM) IN POSTMENOPAUSAL PATIENTS WITH DCIS UNDERGOING LUMPECTOMY PLUS RADIOTHERAPYSpeaker: Patricia A Ganz
Slide 27 / 28
Slide 28 / 28
Page 14
Recommended